The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Activation of Human Brown Adipose Tissue by a β3-Adrenergic Receptor Agonist
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cold-Activated Brown Adipose Tissue in Healthy Men
van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M. A. F. L., Kemerink, G. J., Bouvy, N. D., Schrauwen, P., & Teule, G. J. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808718 · Cited by 3,452
Functional Brown Adipose Tissue in Healthy Adults
Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058
High Incidence of Metabolically Active Brown Adipose Tissue in Healthy Adult Humans
Saito, M., Okamatsu-Ogura, Y., Matsushita, M., Watanabe, K., Yoneshiro, T., Nio-Kobayashi, J., Iwanaga, T., Miyagawa, M., Kameya, T., Nakada, K., et al. (2009) · Diabetes · doi:10.2337/db09-0530 · Cited by 1,848
Brown adipose tissue activity controls triglyceride clearance
Bartelt, A., Bruns, O. T., Reimer, R., Hohenberg, H., Ittrich, H., Peldschus, K., Kaul, M. G., Tromsdorf, U. I., Weller, H., Waurisch, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2297 · Cited by 1,608
Brown adipose tissue regulates glucose homeostasis and insulin sensitivity
Stanford, K. I., Middelbeek, R. J. W., Townsend, K. L., An, D., Nygaard, E. B., Hitchcox, K. M., Markan, K. R., Nakano, K., Hirshman, M. F., Tseng, Y.-H., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62308 · Cited by 1,180
Zingaretti, M. C., Crosta, F., Vitali, A., Guerrieri, M., Frontini, A., Cannon, B., Nedergaard, J., & Cinti, S. (2009) · The FASEB Journal · doi:10.1096/fj.09-133546 · Cited by 725
Thermogenic Activation Induces FGF21 Expression and Release in Brown Adipose Tissue
Hondares, E., Iglesias, R., Giralt, A., Gonzalez, F. J., Giralt, M., Mampel, T., & Villarroya, F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.215889 · Cited by 623
Weyer, C., Tataranni, P. A., Snitker, S., Danforth, E., & Ravussin, E. (1998) · Diabetes · doi:10.2337/diabetes.47.10.1555 · Cited by 188
Larsen, T. M., Toubro, S., van Baak, M. A., Gottesdiener, K. M., Larson, P., Saris, W. H., & Astrup, A. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.4.780 · Cited by 179
Research works printed but not linked: 29
- Arch, 2011, Challenges in β(3)-Adrenoceptor Agonist Drug Development, Ther. Adv. Endocrinol. Metab., 2, 59, 10.1177/2042018811398517 · DOI
- Carey, 2013, Ephedrine activates brown adipose tissue in lean but not obese humans, Diabetologia, 56, 147, 10.1007/s00125-012-2748-1 · DOI
- Cawthorne, 1992, BRL 35135, a potent and selective atypical beta-adrenoceptor agonist, Am. J. Clin. Nutr., 55, 252S, 10.1093/ajcn/55.1.252s · DOI
- Chapple, 2013, A phase II dose-ranging study of mirabegron in patients with overactive bladder, Int. Urogynecol. J., 24, 1447, 10.1007/s00192-013-2042-x · DOI
- Chen, 2013, Brown fat activation mediates cold-induced thermogenesis in adult humans in response to a mild decrease in ambient temperature, J. Clin. Endocrinol. Metab., 98, E1218, 10.1210/jc.2012-4213 · DOI
- Cypess, 2009, Identification and importance of brown adipose tissue in adult humans, N. Engl. J. Med., 360, 1509, 10.1056/NEJMoa0810780 · DOI · Paper page
- Cypess, 2012, Cold but not sympathomimetics activates human brown adipose tissue in vivo, Proc. Natl. Acad. Sci. USA, 109, 10001, 10.1073/pnas.1207911109 · DOI · Paper page
- Cypess, 2013, Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat, Nat. Med., 19, 635, 10.1038/nm.3112 · DOI · Paper page
- de Souza, 1997, CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats, Diabetes, 46, 1257, 10.2337/diab.46.8.1257 · DOI
- Hall, 2011, Quantification of the effect of energy imbalance on bodyweight, Lancet, 378, 826, 10.1016/S0140-6736(11)60812-X · DOI · Paper page
- Jespersen, 2013, A classical brown adipose tissue mRNA signature partly overlaps with brite in the supraclavicular region of adult humans, Cell Metab., 17, 798, 10.1016/j.cmet.2013.04.011 · DOI
- Kim, 2006, Effect of adipocyte beta3-adrenergic receptor activation on the type 2 diabetic MKR mice, Am. J. Physiol. Endocrinol. Metab., 290, E1227, 10.1152/ajpendo.00344.2005 · DOI
- Lidell, 2013, Evidence for two types of brown adipose tissue in humans, Nat. Med., 19, 631, 10.1038/nm.3017 · DOI · Paper page
- Malik, 2012, Proarrhythmic safety of repeat doses of mirabegron in healthy subjects: a randomized, double-blind, placebo-, and active-controlled thorough QT study, Clin. Pharmacol. Ther., 92, 696, 10.1038/clpt.2012.181 · DOI
- Masutani, 2013, β3-Adrenergic receptor antagonist improves exercise performance in pacing-induced heart failure, Am. J. Physiol. Heart Circ. Physiol., 305, H923, 10.1152/ajpheart.00371.2012 · DOI
- Muzik, 2013, 15O PET measurement of blood flow and oxygen consumption in cold-activated human brown fat, J. Nucl. Med., 54, 523, 10.2967/jnumed.112.111336 · DOI
- Ouellet, 2012, Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans, J. Clin. Invest., 122, 545, 10.1172/JCI60433 · DOI · Paper page
- Redman, 2007, Lack of an effect of a novel beta3-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized study, J. Clin. Endocrinol. Metab., 92, 527, 10.1210/jc.2006-1740 · DOI · Paper page
- Sacco, 2012, Mirabegron: a review of recent data and its prospects in the management of overactive bladder, Ther. Adv. Urol., 4, 315, 10.1177/1756287212457114 · DOI
- Sacks, 2013, Adult epicardial fat exhibits beige features, J. Clin. Endocrinol. Metab., 98, E1448, 10.1210/jc.2013-1265 · DOI
- Sharp, 2012, Human BAT possesses molecular signatures that resemble beige/brite cells, PLoS ONE, 7, e49452, 10.1371/journal.pone.0049452 · DOI
- Takasu, 2007, Effect of (R)-2-(2-aminothiazol-4-yl)-4′-2-[(2-hydroxy-2-phenylethyl)amino]ethyl acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function, J. Pharmacol. Exp. Ther., 321, 642, 10.1124/jpet.106.115840 · DOI
- Ursino, 2009, The beta3-adrenoceptor as a therapeutic target: current perspectives, Pharmacol. Res., 59, 221, 10.1016/j.phrs.2009.01.002 · DOI
- van der Lans, 2013, Cold acclimation recruits human brown fat and increases nonshivering thermogenesis, J. Clin. Invest., 123, 3395, 10.1172/JCI68993 · DOI · Paper page
- Vansal, 1999, Direct effects of ephedrine isomers on human beta-adrenergic receptor subtypes, Biochem. Pharmacol., 58, 807, 10.1016/S0006-2952(99)00152-5 · DOI
- Villarroya, 2013, An endocrine role for brown adipose tissue?, Am. J. Physiol. Endocrinol. Metab., 305, E567, 10.1152/ajpendo.00250.2013 · DOI
- Vosselman, 2012, Systemic β-adrenergic stimulation of thermogenesis is not accompanied by brown adipose tissue activity in humans, Diabetes, 61, 3106, 10.2337/db12-0288 · DOI
- Wu, 2012, Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human, Cell, 150, 366, 10.1016/j.cell.2012.05.016 · DOI · Paper page
- Yoneshiro, 2013, Recruited brown adipose tissue as an antiobesity agent in humans, J. Clin. Invest., 123, 3404, 10.1172/JCI67803 · DOI
Cited by
Chait, A., & den Hartigh, L. J. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00022 · Cited by 1,529
Targeting adipose tissue in the treatment of obesity-associated diabetes
Kusminski, C. M., Bickel, P. E., & Scherer, P. E. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.75 · Cited by 678
Li, G., Xie, C., Lu, S., Nichols, R. G., Tian, Y., Li, L., Patel, D., Ma, Y., Brocker, C. N., Yan, T., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.019 · Cited by 667
The obese adipose tissue microenvironment in cancer development and progression
Quail, D. F., & Dannenberg, A. J. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0126-x · Cited by 542
Accumulation of succinate controls activation of adipose tissue thermogenesis
Mills, E. L., Pierce, K. A., Jedrychowski, M. P., Garrity, R., Winther, S., Vidoni, S., Yoneshiro, T., Spinelli, J. B., Lu, G. Z., Kazak, L., et al. (2018) · Nature · doi:10.1038/s41586-018-0353-2 · Cited by 539
Mapping of human brown adipose tissue in lean and obese young men
Leitner, B. P., Huang, S., Brychta, R. J., Duckworth, C. J., Baskin, A. S., McGehee, S., Tal, I., Dieckmann, W., Gupta, G., Kolodny, G. M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705287114 · Cited by 530
Human Brown Adipocyte Thermogenesis Is Driven by β2-AR Stimulation
Blondin, D. P., Nielsen, S., Kuipers, E. N., Severinsen, M. C., Jensen, V. H., Miard, S., Jespersen, N. Z., Kooijman, S., Boon, M. R., Fortin, M., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.07.005 · Cited by 331
Brown and beige fat: Molecular parts of a thermogenic machine
Cohen, P., & Spiegelman, B. M. (2015) · Diabetes · doi:10.2337/db15-0318 · Cited by 259
GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice
Samms, R. J., Christe, M. E., Collins, K. A. L., Pirro, V., Droz, B. A., Holland, A. K., Friedrich, J. L., Wojnicki, S., Konkol, D. L., Cosgrove, R., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146353 · Cited by 256
Pharmacotherapy of obesity: available medications and drugs under investigation.
Pilitsi, E., Farr, O. M., Polyzos, S. A., Perakakis, N., Nolen-Doerr, E., Papathanasiou, A.-E., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.10.010 · Cited by 248
Yau, W. W., Singh, B. K., Lesmana, R., Zhou, J., Sinha, R. A., Wong, K. A., Wu, Y., Bay, B.-H., Sugii, S., Sun, L., et al. (2019) · Autophagy · doi:10.1080/15548627.2018.1511263 · Cited by 229
Bertholet, A. M., Kazak, L., Chouchani, E. T., Bogaczyńska, M. G., Paranjpe, I., Wainwright, G. L., Bétourné, A., Kajimura, S., Spiegelman, B. M., & Kirichok, Y. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.002 · Cited by 225
Human Brown Adipose Tissue: What We Have Learned So Far
Betz, M. J., & Enerbäck, S. (2015) · Diabetes · doi:10.2337/db15-0146 · Cited by 223
Glucagon increases energy expenditure independently of brown adipose tissue activation in humans
Salem, V., Izzi‐Engbeaya, C., Coello, C., Thomas, D. B., Chambers, E. S., Comninos, A. N., Buckley, A., Win, Z., Al‐Nahhas, A., Rabiner, E. A., et al. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12585 · Cited by 167
‘Browning’ the cardiac and peri-vascular adipose tissues to modulate cardiovascular risk
Aldiss, P., Davies, G., Woods, R., Budge, H., Sacks, H. S., & Symonds, M. E. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.074 · Cited by 148
Glucagon Regulation of Energy Expenditure
Kleinert, M., Sachs, S., Habegger, K. M., Hofmann, S. M., & Müller, T. D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215407 · Cited by 147
Li, G., Xie, C., Lu, S., Nichols, R. G., Tian, Y., Li, L., Patel, D., Ma, Y., Brocker, C. N., Yan, T., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.007 · Cited by 144
“The mechanism by which EODF induces higher energy expenditure might differ from that of cold exposure; cold exposure is closely tied to b-AR signaling (Cypess et al., 2015; Mund and Frishman, 2013), while fasting is known to suppress norepinephrine turnover (Knehans and Romsos, 1983) and norepinephrine-induced thermog…”
Jiang, Y., Berry, D. C., & Graff, J. M. (2017) · eLife · doi:10.7554/elife.30329 · Cited by 135
van Woerden, G., van Veldhuisen, D. J., Westenbrink, B. D., de Boer, R. A., Rienstra, M., & Gorter, T. M. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2741 · Cited by 128
Obesity: A neuroimmunometabolic perspective
Larabee, C. M., Neely, O. C., & Domingos, A. I. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0283-6 · Cited by 123
Kolumam, G., Chen, M. Z., Tong, R., Zavala-Solorio, J., Kates, L., van Bruggen, N., Ross, J., Wyatt, S. K., Gandham, V. D., Carano, R. A. D., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.05.028 · Cited by 108
Liu, X., Zhang, Z., Song, Y., Xie, H., & Dong, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1065263 · Cited by 102
Vasan, S. K., Noordam, R., Gowri, M. S., Neville, M. J., Karpe, F., & Christodoulides, C. (2019) · Diabetologia · doi:10.1007/s00125-019-4947-5 · Cited by 76
The new era of drug therapy for obesity: the evidence and the expectations
Jones, B. J., & Bloom, S. R. (2015) · Drugs · doi:10.1007/s40265-015-0410-1 · Cited by 58
Liu, T., Ji, R.-L., & Tao, Y.-X. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108044 · Cited by 34
Bargut, T. C. L., Martins, F. F., Santos, L. P., Aguila, M. B., & Mandarim-de-Lacerda, C. A. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.12.003 · Cited by 34
Central vs. Peripheral Action of Thyroid Hormone in Adaptive Thermogenesis: A Burning Topic
Zekri, Y., Flamant, F., & Gauthier, K. (2021) · Cells · doi:10.3390/cells10061327 · Cited by 27
Targeting skeletal muscle mitochondrial health in obesity
Pileggi, C. A., Hooks, B. G., McPherson, R., Dent, R. R. M., & Harper, M.-E. (2022) · Clinical Science · doi:10.1042/cs20210506 · Cited by 21
Perez, L. C., Perez, L. T., Nene, Y., Umpierrez, G. E., Davis, G. M., & Pasquel, F. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1037458 · Cited by 17
Yamanishi, K., Maeda, S., Kuwahara-Otani, S., Hashimoto, T., Ikubo, K., Mukai, K., Nakasho, K., Gamachi, N., El-Darawish, Y., Li, W., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1684-3 · Cited by 15
Metadata
- Authors
- Cypess, A. M., Weiner, L. S., Roberts-Toler, C., Elía, E. F., Kessler, S. H., Kahn, P. A., English, J., Chatman, K., Trauger, S. A., Doria, A., & Kolodny, G. M.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 21
- Issue
- 1
- Pages
- 33-38
- ISSN
- 1550-4131
- Cited by
- 1,027
- References
- 9
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 370 d)
- Funders
- Fundación Alfonso Martín Escudero
- National Institutes of Health (K23 DK081604, P30 DK036836)
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Research Resources (UL1 RR025758)
- National Center for Advancing Translational Sciences (UL1TR000170, UL1TR001102)
- Harvard University
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.